- Home
- MSGE vs ELVN Comparison
MSGE vs ELVN Comparison
Compare MSGE & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSGE | ELVN |
|---|---|---|
| Founded | 2020 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.2B |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MSGE | ELVN |
|---|---|---|
| Price | $79.51 | $46.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $91.63 | $73.90 |
| AVG Volume (30 Days) | 348.5K | ★ 1.1M |
| Earning Date | 11-05-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.22 | 3.17 |
| EPS | ★ 1.38 | N/A |
| Revenue | ★ $942,734,000.00 | N/A |
| Revenue This Year | $6.13 | N/A |
| Revenue Next Year | $4.62 | N/A |
| P/E Ratio | $60.57 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $41.65 | $14.79 |
| 52 Week High | $90.41 | $62.32 |
Technical Indicators
Market Signals| Indicator | MSGE | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 48.58 | 28.85 |
| Support Level | $74.65 | $25.63 |
| Resistance Level | $82.79 | $48.53 |
| Average True Range (ATR) | 2.65 | 2.06 |
| MACD | 0.08 | -0.42 |
| Stochastic Oscillator | 34.83 | 16.09 |
Price Performance
Historical ComparisonAbout MSGE Madison Square Garden Entertainment Corp.
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.